Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Anika Therapeutics (ANIK) Shares Issued (2016 - 2025)

Historic Shares Issued for Anika Therapeutics (ANIK) over the last 16 years, with Q2 2025 value amounting to $261000.0.

  • Anika Therapeutics' Shares Issued fell 3273.2% to $261000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $558000.0, marking a year-over-year decrease of 2657.89%. This contributed to the annual value of $708000.0 for FY2024, which is 1204.97% down from last year.
  • Latest data reveals that Anika Therapeutics reported Shares Issued of $261000.0 as of Q2 2025, which was down 3273.2% from $297000.0 recorded in Q4 2024.
  • Over the past 5 years, Anika Therapeutics' Shares Issued peaked at $650000.0 during Q4 2022, and registered a low of $7000.0 during Q1 2023.
  • Moreover, its 5-year median value for Shares Issued was $323000.0 (2023), whereas its average is $297250.0.
  • Its Shares Issued has fluctuated over the past 5 years, first tumbled by 9217.03% in 2021, then surged by 47017.54% in 2022.
  • Quarter analysis of 5 years shows Anika Therapeutics' Shares Issued stood at $114000.0 in 2021, then soared by 470.18% to $650000.0 in 2022, then crashed by 46.31% to $349000.0 in 2023, then dropped by 14.9% to $297000.0 in 2024, then fell by 12.12% to $261000.0 in 2025.
  • Its Shares Issued stands at $261000.0 for Q2 2025, versus $297000.0 for Q4 2024 and $388000.0 for Q2 2024.